LARGE Antikörper (AA 35-142)
Kurzübersicht für LARGE Antikörper (AA 35-142) (ABIN5541530)
Target
Alle LARGE Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 35-142
-
Spezifität
- This antibody recognizes human LARGE1, a glycosyltransferase localizing mainly to the Golgi apparatus. Crossreactivity with LARGE2 was not determined.
-
Aufreinigung
- Protein-A affinity chromatography (> 95% pure by SDS-PAGE)
-
Immunogen
- Recombinant fragment of human LARGE1 (amino acids 35-142)
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Flow cytometry. Western blot.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 95 % pure by SDS-PAGE) Buffer System: Phosphate buffered saline (PBS) Preservatives: 15 mM sodium azide, approx. pH 7.4
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8°C. DO NOT FREEZE! Shelf life: one year from despatch.
-
Haltbarkeit
- 12 months
-
-
- LARGE (Like-Glycosyltransferase (LARGE))
-
Andere Bezeichnung
- large
-
Hintergrund
- LARGE1 serves as a glycosyltransferase which participates in glycosylation of the muscle membrane protein alpha-dystroglycan. Mutations of LARGE1 lead to hypoglycosylation of alpha-dystroglycan and cause congenital muscular dystrophy (MDC1D) associated with severe mental retardation. Altered alpha-dystroglycan glycosylation may also play a role in cancer, as hypoglycosylation of the protein and loss of laminin binding have been demonstrated in invasive carcinoma cells.
-
UniProt
- O95461
Target
-